Late sodium current blocker GS967 inhibits persistent currents induced by familial hemiplegic migraine type 3 mutations of the SCN1A gene.
R BarbieriS BertelliM PuschPaola GavazzoPublished in: The journal of headache and pain (2019)
In conclusion, late Na+ current blockers appear a promising specific pharmacological treatment of FHM3.